Literature DB >> 8610131

Mutants in the Exo I motif of Escherichia coli dnaQ: defective proofreading and inviability due to error catastrophe.

I J Fijalkowska1, R M Schaaper.   

Abstract

The Escherichia coli dnaQ gene encodes the proofreading 3' exonuclease (epsilon subunit) of DNA polymerase III holoenzyme and is a critical determinant of chromosomal replication fidelity. We constructed by site-specific mutagenesis a mutant, dnaQ926, by changing two conserved amino acid residues (Asp-12-->Ala and Glu-14-->Ala) in the Exo I motif, which, by analogy to other proofreading exonucleases, is essential for the catalytic activity. When residing on a plasmid, dnaQ926 confers a strong, dominant mutator phenotype, suggesting that the protein, although deficient in exonuclease activity, still binds to the polymerase subunit (alpha subunit or dnaE gene product). When dnaQ926 was transferred to the chromosome, replacing the wild-type gene, the cells became inviable. However, viable dnaQ926 strains could be obtained if they contained one of the dnaE alleles previously characterized in our laboratory as antimutator alleles or if it carried a multicopy plasmid containing the E. coli mutL+ gene. These results suggest that loss of proofreading exonuclease activity in dnaQ926 is lethal due to excessive error rates (error catastrophe). Error catastrophe results from both the loss of proofreading and the subsequent saturation of DNA mismatch repair. The probability of lethality by excessive mutation is supported by calculations estimating the number of inactivating mutations in essential genes per chromosome replication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8610131      PMCID: PMC39723          DOI: 10.1073/pnas.93.7.2856

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  The maintenance of the accuracy of protein synthesis and its relevance to ageing.

Authors:  L E ORGEL
Journal:  Proc Natl Acad Sci U S A       Date:  1963-04       Impact factor: 11.205

Review 2.  Mutator phenotype may be required for multistage carcinogenesis.

Authors:  L A Loeb
Journal:  Cancer Res       Date:  1991-06-15       Impact factor: 12.701

3.  Saturation of mismatch repair in the mutD5 mutator strain of Escherichia coli.

Authors:  V Damagnez; M P Doutriaux; M Radman
Journal:  J Bacteriol       Date:  1989-08       Impact factor: 3.490

4.  Escherichia coli mutator mutD5 is defective in the mutHLS pathway of DNA mismatch repair.

Authors:  R M Schaaper
Journal:  Genetics       Date:  1989-02       Impact factor: 4.562

5.  The polymerase chain reaction colony miniprep.

Authors:  L I Zon; D M Dorfman; S H Orkin
Journal:  Biotechniques       Date:  1989 Jul-Aug       Impact factor: 1.993

6.  A constant rate of spontaneous mutation in DNA-based microbes.

Authors:  J W Drake
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

Review 7.  Fidelity mechanisms in DNA replication.

Authors:  H Echols; M F Goodman
Journal:  Annu Rev Biochem       Date:  1991       Impact factor: 23.643

8.  Isolation and characterization of mutants with deletions in dnaQ, the gene for the editing subunit of DNA polymerase III in Salmonella typhimurium.

Authors:  E D Lancy; M R Lifsics; D G Kehres; R Maurer
Journal:  J Bacteriol       Date:  1989-10       Impact factor: 3.490

9.  The extreme mutator effect of Escherichia coli mutD5 results from saturation of mismatch repair by excessive DNA replication errors.

Authors:  R M Schaaper; M Radman
Journal:  EMBO J       Date:  1989-11       Impact factor: 11.598

10.  The 3'-5' exonuclease of DNA polymerase I of Escherichia coli: contribution of each amino acid at the active site to the reaction.

Authors:  V Derbyshire; N D Grindley; C M Joyce
Journal:  EMBO J       Date:  1991-01       Impact factor: 11.598

View more
  78 in total

Review 1.  Composing life.

Authors:  D Segré; D Lancet
Journal:  EMBO Rep       Date:  2000-09       Impact factor: 8.807

2.  Comparative genome analysis of the pathogenic spirochetes Borrelia burgdorferi and Treponema pallidum.

Authors:  G Subramanian; E V Koonin; L Aravind
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  The C-terminal domain of dnaQ contains the polymerase binding site.

Authors:  S A Taft-Benz; R M Schaaper
Journal:  J Bacteriol       Date:  1999-05       Impact factor: 3.490

4.  Efficient gene targeted random mutagenesis in genetically stable Escherichia coli strains.

Authors:  C Fabret; S Poncet; S Danielsen; T V Borchert; S D Ehrlich; L Jannière
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

5.  Genetic factors affecting the impact of DNA polymerase delta proofreading activity on mutation avoidance in yeast.

Authors:  H T Tran; N P Degtyareva; D A Gordenin; M A Resnick
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

Review 6.  Somatic mutations in aging, cancer and neurodegeneration.

Authors:  Scott R Kennedy; Lawrence A Loeb; Alan J Herr
Journal:  Mech Ageing Dev       Date:  2011-11-03       Impact factor: 5.432

Review 7.  DNA replication fidelity in Escherichia coli: a multi-DNA polymerase affair.

Authors:  Iwona J Fijalkowska; Roel M Schaaper; Piotr Jonczyk
Journal:  FEMS Microbiol Rev       Date:  2012-04-05       Impact factor: 16.408

8.  Dysfunctional proofreading in the Escherichia coli DNA polymerase III core.

Authors:  Duane A Lehtinen; Fred W Perrino
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

9.  The theta subunit of Escherichia coli DNA polymerase III: a role in stabilizing the epsilon proofreading subunit.

Authors:  Sharon A Taft-Benz; Roel M Schaaper
Journal:  J Bacteriol       Date:  2004-05       Impact factor: 3.490

10.  Structure of the Escherichia coli DNA polymerase III epsilon-HOT proofreading complex.

Authors:  Thomas W Kirby; Scott Harvey; Eugene F DeRose; Sergey Chalov; Anna K Chikova; Fred W Perrino; Roel M Schaaper; Robert E London; Lars C Pedersen
Journal:  J Biol Chem       Date:  2006-09-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.